Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-01-24 00:00:00 ET · period of report 2022-01-20 · accession 0001209191-22-004606 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-24 | 2022-01-20+ | FATE | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $39.66 | -40.0K | 431.5K | -8% | -$1.59M |
| DM | 2022-01-24 | 2022-01-20+ | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.72 | +40.0K | 461.5K | +9% | +$108.9K |
| DM | 2022-01-24 | 2022-01-20+ | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.72 | -40.0K | 20.0K | -67% | -$108.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-21 | S | D | 10,000 | $38.02 | 431,546 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-21 | M | A | 10,000 | $2.70 | 441,546 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-20 | S | D | 30,000 | $40.21 | 431,546 | D | — | — | |
| 4 | Common | Common Stock | 2022-01-20 | M | A | 30,000 | $2.73 | 461,546 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-01-21 | M | D | 10,000 | $2.70 | 89,446 | D | $2.70 · — to 2026-01-11 | 10,000 Common Stock | (F2) This option is fully vested. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-01-20 | M | D | 30,000 | $2.73 | 20,000 | D | $2.73 · — to 2027-01-03 | 30,000 Common Stock | (F2) This option is fully vested. |